CAS RN: 185213-52-9
Scabertopin
Product Availability
Choose a grade to view its available package options.
5 package records4 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260606 |
10mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250412 |
1mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250730 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250902 |
5mg |
In stock |
Shanghai | | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250418 |
1mg / 5mg |
Out of stock |
| 5-7 business days | Inquiry |
-
Product code:
starshine_CAS185213-52-9
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
185213-52-9 / [(3S,4R,8R,9Z,12S)-10-methyl-5-methylidene-6,14-dioxo-7,13-dioxatricyclo[10.2.1.04,8]pentadeca-1(15),9-dien-3-yl] (Z)-2-methylbut-2-enoate
Standard CAS: 185213-52-9
Multi CAS: No
Basic Information
CAS
185213-52-9
Multi CAS
No
Molecular Formula
C20H22O6
Molecular Weight
358.400000
Exact Mass
358.141638
SMILES
C/C=C(/C)\C(=O)O[C@H]1CC2=C[C@H](C/C(=C\[C@@H]3[C@@H]1C(=C)C(=O)O3)/C)OC2=O
InChI
InChI=1S/C20H22O6/c1-5-11(3)18(21)25-16-9-13-8-14(24-20(13)23)6-10(2)7-15-17(16)12(4)19(22)26-15/h5,7-8,14-17H,4,6,9H2,1-3H3/b10-7+,11-5-/t14-,15-,16+,17+/m1/s1
InChIKey
FTPHYXGWMIZVMP-GAFRNKKQSA-N
Computed Properties
Structural Parameters
Heavy atom count
26
Fraction Csp3
0.45
Rotatable bonds
2
H-bond acceptors
6
Molar refractivity
92.78
TPSA
78.9
LogP / Solubility
WLOGP
2.55
MLOGP
2.27
XLogP3
2.6
Consensus LogP
2.47
Log S (ESOL)
-3.54
Class (ESOL)
Poorly soluble
Log S (Ali)
-4.34
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.35
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3.09
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
8